- Home
- BNED vs ALEC Comparison
BNED vs ALEC Comparison
Compare BNED & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BNED | ALEC |
|---|---|---|
| Founded | 1965 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 284.0M | 241.2M |
| IPO Year | 2015 | 2019 |
Fundamental Metrics
Financial Performance| Metric | BNED | ALEC |
|---|---|---|
| Price | $8.43 | $2.20 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $3.33 |
| AVG Volume (30 Days) | 246.6K | ★ 838.1K |
| Earning Date | 04-17-2026 | 05-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 89.47 | N/A |
| EPS | ★ 0.19 | N/A |
| Revenue | ★ $1,610,170,000.00 | $21,045,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $45.24 |
| P/E Ratio | $44.16 | ★ N/A |
| Revenue Growth | ★ 2.75 | N/A |
| 52 Week Low | $5.90 | $0.87 |
| 52 Week High | $12.19 | $3.40 |
Technical Indicators
Market Signals| Indicator | BNED | ALEC |
|---|---|---|
| Relative Strength Index (RSI) | 48.72 | 55.95 |
| Support Level | $8.23 | $1.22 |
| Resistance Level | $9.67 | $2.53 |
| Average True Range (ATR) | 0.39 | 0.19 |
| MACD | 0.04 | -0.02 |
| Stochastic Oscillator | 57.26 | 44.85 |
Price Performance
Historical ComparisonAbout BNED Barnes & Noble Education Inc
Barnes & Noble Education Inc is a contract operator of physical and virtual bookstores for college and university campuses and K-12 institutions across the United States. The company is also a textbook wholesaler and inventory management hardware and software provider. It offers course materials through physical and online bookstores, including new and used print textbooks, rental options, digital textbooks, and publisher-hosted digital courseware. Products are also offered directly to students through Textbooks.com. The majority of the company's revenue is derived from the sale of products through its bookstore locations, including virtual bookstores, and the bookstore affiliated e-commerce websites.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.